I believe the rules of ASCO require the "embargo" of the final data pending the ASCO presentation, so don't blame Generex for that delay. It does mean that if you are a bull on GNBT you are going to have a long wait for any more bump from AE-37!! Unless they come up with a partner in the interim.....???
While we are waiting, an update on the status of Ora-lyn in India would be nice....
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.